← Back to Search

Other

KX- 826 dosed at 2.5mg for Male Pattern Baldness

Phase 2
Waitlist Available
Research Sponsored by Suzhou Kintor Pharmaceutical Inc,
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6,12,18 and 24 weeks
Awards & highlights

Study Summary

This trial will test a new drug to see if it's effective and safe for male pattern baldness.

Eligible Conditions
  • Male Pattern Baldness
  • Alopecia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6,12,18 and 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6,12,18 and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment of change in Target Area Hair Counts
Secondary outcome measures
Assessment of change in Hair Growth Assessment score

Trial Design

4Treatment groups
Experimental Treatment
Group I: Arm DExperimental Treatment1 Intervention
Matching placebo to KX-826
Group II: Arm CExperimental Treatment1 Intervention
KX-826: 5mg twice daily
Group III: Arm BExperimental Treatment1 Intervention
KX-826: 5mg once daily
Group IV: Arm AExperimental Treatment1 Intervention
KX-826: 2.5mg twice daily
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Matching placebo to KX-826
2022
Completed Phase 2
~130
KX-826 dosed at 5mg
2022
Completed Phase 2
~130
KX- 826 dosed at 2.5mg
2022
Completed Phase 2
~130

Find a Location

Who is running the clinical trial?

IQVIA BiotechIndustry Sponsor
19 Previous Clinical Trials
5,285 Total Patients Enrolled
Suzhou Kintor Pharmaceutical Inc,Lead Sponsor
14 Previous Clinical Trials
2,720 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who does this trial seek to enroll as participants?

"The ideal candidate for this trial must be suffering from alopecia and between 18-70 years old. Currently, the study is looking to enroll 123 patients."

Answered by AI

Does KX- 826 carry any risk when dosed at 2.5mg?

"While there is no data currently supporting KX- 826's efficacy, there are Phase 2 clinical trials underway which suggest that the drug is safe when dosed at 2.5mg."

Answered by AI

Is this study being conducted in more than one place?

"Currently, this trial is being conducted in 15 different locations. These include Miami, Portsmouth and San Antonio amongst others. To reduce the demand of travel, it would be best to enroll at the clinic nearest you."

Answered by AI

Does this research include patients that are over 35 years old?

"The age range that is able to participate in this clinical trial starts at 18 and ends when the patient reaches 70 years old."

Answered by AI

Are people with the required conditions able to sign up for this test right now?

"The clinical trial was first posted on 1/31/2022 and was most recently updated on 9/24/2022. According to the data available on clinicaltrials.gov, this study is not enrolling patients at this time, though there are 93 other studies actively recruiting participants right now"

Answered by AI

Who else is applying?

What state do they live in?
New York
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
2

How responsive is this trial?

Typically responds via
Phone Call
Recent research and studies
clinicaltrials.govStudy
To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia
2022. "To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05218642.
~39 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top